Cutaneous malignant and premalignant conditions caused by chronic arsenicosis from contaminated ground water consumption: A profile of patients from eastern India

SKINmed

Volumn 11, Issue 4, 2013, Pages 211-216

  Ghosh, Sudip Kumar ^a   Bandyopadhyay, Debabrata ^a   Bandyopadhyay, Samik Kumar ^a   Debbarma, Kuntal ^a  

^a R G KAR MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER;

ADULT; AGED; ARSENIC POISONING; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; FEMALE; HAND DISEASE; HUMAN; INDIA; KERATOSIS; MALE; MIDDLE AGED; PRECANCER; SKIN DISEASE; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ARSENIC POISONING; BOWEN'S DISEASE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CHRONIC DISEASE; DRINKING WATER; FEMALE; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; INDIA; KERATOSIS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS;

EID: 84887134484     PISSN: 15409740     EISSN: 17517125     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ratnaike RN. Acute and chronic arsenic toxicity. Postgrad Med J. 2003;79:391-396.
2. Guha Mazumder DN. Chronic arsenic toxicity & human health. Indian J Med Res. 2008;128:436-447.
3. Maloney ME. Arsenic in dermatology. Dermatol Surg. 1996;22:301-304.
4. Watson K, Creamer D. Arsenic-induced keratoses and Bowen’s disease. Clin Exp Dermatol. 2004;29:46-48.
5. Walvekar RR, Kane SV, Nadkarni MS, et al. Chronic arsenic poisoning: a global health issue—a report of multiple primary cancers. J Cutan Pathol. 2007;34:203-206.
6. World Health Organization Regional Office for South- East Asia. Arsenicosis Case-Detection, Management and Surveillance. Report of a Regional Consultation New Delhi, India. November 5-9, 2002. New Delhi; 2003:7.
7. Mazumder DG, Ghosh A, Majumdar KK, et al. Arsenic contamination of ground water and its health impact on population of district of Nadia, West Bengal, India. Indian J Community Med. 2010;35:331-338.
8. Smith ML. Environmental and sports-related skin diseases. In: Bolognia JL, Jorizzo JL, Rapini RL eds. Dermatology. 2nd ed. Philadelphia, PA: Mosby-Elsevier. 2010:1353-1375.
9. Saha KC. Cutaneous malignancy in arsenicosis. Br J Dermatol. 2001;145:185.
10. Lien HC, Tsai TF, Lee YY, Hsiao CH. Merkel cell carcinoma and chronic arsenicism. J Am Acad Dermatol. 1999;41:641-643.
11. Beane Freeman LE, Dennis LK, Lynch CF, Thorne PS, Just CL. Toenail arsenic content and cutaneous melanoma in Iowa. Am J Epidemiol. 2004;160:679-687.
12. Tondel M, Rahman M, Magnuson A, et al. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. Environ Health Perspect. 1999;107:727-729.
13. Ohtsuka R, Sudo N, Sekiyama M, et al. Gender difference in daily time and space use among Bangladeshi villagers under arsenic hazard: application of the compact spot-check method. J Biosoc Sci. 2004;36:317-332.
14. Wong SS, Tan KC, Goh CL. Cutaneous manifestations of chronic arsenicism: review of seventeen cases. J Am Acad Dermatol. 1998;38:179-185.
15. Centeno JA, Mullick FG, Martinez L, et al. Pathology related to chronic arsenic exposure. Environ Health Perspect. 2002;110. suppl 5:883-886.